News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
741,506 Results
Type
Article (43840)
Company Profile (319)
Press Release (697334)
Multimedia
Podcasts (115)
Webinars (19)
Section
Business (211035)
Career Advice (2109)
Deals (36766)
Drug Delivery (123)
Drug Development (83424)
Employer Resources (176)
FDA (16815)
Job Trends (15501)
News (357410)
Policy (34133)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2613)
Accelerated approval (31)
Adcomms (26)
Allergies (143)
Alliances (51595)
ALS (172)
Alzheimer's disease (1680)
Antibody-drug conjugate (ADC) (318)
Approvals (17075)
Artificial intelligence (523)
Autoimmune disease (146)
Automation (37)
Bankruptcy (373)
Best Places to Work (11773)
BIOSECURE Act (21)
Biosimilars (193)
Biotechnology (189)
Bladder cancer (157)
Brain cancer (59)
Breast cancer (641)
Cancer (4829)
Cardiovascular disease (410)
Career advice (1788)
Career pathing (36)
CAR-T (279)
CDC (47)
Celiac Disease (2)
Cell therapy (742)
Cervical cancer (36)
Clinical research (71090)
Collaboration (1724)
Company closure (4)
Compensation (1147)
Complete response letters (60)
COVID-19 (2783)
CRISPR (94)
C-suite (838)
Cystic fibrosis (148)
Data (6186)
Decentralized trials (2)
Denatured (36)
Depression (133)
Diabetes (501)
Diagnostics (6757)
Digital health (44)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (249)
Drug pricing (203)
Drug shortages (31)
Duchenne muscular dystrophy (227)
Earnings (91768)
Editorial (58)
Employer branding (21)
Employer resources (154)
Events (120166)
Executive appointments (985)
FDA (19924)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (10)
Frontotemporal dementia (23)
Funding (1464)
Gene editing (200)
Generative AI (44)
Gene therapy (604)
GLP-1 (1011)
Government (4795)
Grass and pollen (7)
Guidances (384)
Healthcare (19063)
HIV (55)
Huntington's disease (45)
IgA nephropathy (83)
Immunology and inflammation (256)
Immuno-oncology (54)
Indications (104)
Infectious disease (3042)
Inflammatory bowel disease (192)
Inflation Reduction Act (14)
Influenza (110)
Intellectual property (247)
Interviews (326)
IPO (16921)
IRA (56)
Job creations (4069)
Job search strategy (1498)
JPM (63)
Kidney cancer (15)
Labor market (83)
Layoffs (574)
Leadership (34)
Legal (8421)
Liver cancer (92)
Longevity (15)
Lung cancer (646)
Lymphoma (374)
Machine learning (43)
Management (60)
Manufacturing (805)
MASH (166)
Medical device (13847)
Medtech (13899)
Mergers & acquisitions (20903)
Metabolic disorders (1287)
Multiple sclerosis (155)
NASH (18)
Neurodegenerative disease (315)
Neuropsychiatric disorders (89)
Neuroscience (2917)
Neurotech (1)
NextGen: Class of 2026 (6655)
Non-profit (4567)
Now hiring (65)
Obesity (608)
Opinion (285)
Ovarian cancer (165)
Pain (213)
Pancreatic cancer (224)
Parkinson's disease (282)
Partnered (34)
Patents (494)
Patient recruitment (476)
Peanut (58)
People (60863)
Pharmaceutical (90)
Pharmacy benefit managers (31)
Phase 1 (22072)
Phase 2 (31261)
Phase 3 (23427)
Pipeline (5119)
Policy (295)
Postmarket research (2655)
Preclinical (9380)
Press Release (68)
Prostate cancer (236)
Psychedelics (49)
Radiopharmaceuticals (284)
Rare diseases (848)
Real estate (6311)
Recruiting (71)
Regulatory (25323)
Reports (51)
Research institute (2435)
Resumes & cover letters (360)
Rett syndrome (27)
RNA editing (17)
RSV (76)
Schizophrenia (154)
Series A (243)
Series B (187)
Service/supplier (11)
Sickle cell disease (99)
Special edition (24)
Spinal muscular atrophy (160)
Sponsored (42)
Startups (3767)
State (2)
Stomach cancer (18)
Supply chain (106)
Tariffs (96)
The Weekly (77)
Vaccines (1014)
Venture capital (88)
Weight loss (401)
Women's health (87)
Worklife (18)
Date
Today (2)
Last 7 days (600)
Last 30 days (1971)
Last 365 days (30225)
2026 (2856)
2025 (30695)
2024 (35781)
2023 (40642)
2022 (51809)
2021 (56341)
2020 (54811)
2019 (47431)
2018 (35797)
2017 (33164)
2016 (32687)
2015 (38627)
2014 (32530)
2013 (27645)
2012 (29744)
2011 (30499)
2010 (28506)
Location
Africa (801)
Alabama (83)
Alaska (7)
Arizona (312)
Arkansas (14)
Asia (42131)
Australia (6752)
California (11221)
Canada (3273)
China (1122)
Colorado (474)
Connecticut (473)
Delaware (336)
Europe (90302)
Florida (1668)
Georgia (353)
Hawaii (3)
Idaho (61)
Illinois (868)
India (65)
Indiana (523)
Iowa (22)
Japan (429)
Kansas (125)
Kentucky (38)
Louisiana (26)
Maine (72)
Maryland (1381)
Massachusetts (8085)
Michigan (322)
Minnesota (625)
Mississippi (5)
Missouri (125)
Montana (31)
Nebraska (28)
Nevada (122)
New Hampshire (78)
New Jersey (2985)
New Mexico (29)
New York (2965)
North Carolina (1459)
North Dakota (8)
Northern California (5458)
Ohio (331)
Oklahoma (22)
Oregon (46)
Pennsylvania (2271)
Puerto Rico (22)
Rhode Island (47)
South America (1176)
South Carolina (66)
South Dakota (1)
Southern California (4367)
Tennessee (172)
Texas (1733)
United States (39905)
Utah (336)
Vermont (1)
Virginia (272)
Washington D.C. (81)
Washington State (923)
West Virginia (4)
Wisconsin (112)
Wyoming (2)
741,506 Results for "catalyst pharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
The University of Notre Dame and Catalyst Pharmaceuticals Host Inaugural Catalyst Advocacy Scholars Summit (CASS)
January 5, 2026
·
2 min read
Press Releases
Catalyst Pharmaceuticals Receives Prestigious Ranking on Forbes 2026 List of America’s Most Successful Small-Cap Companies
January 8, 2026
·
2 min read
Press Releases
Catalyst Pharmaceuticals to Participate in the 44th Annual J.P. Morgan Healthcare Conference
December 16, 2025
·
2 min read
Press Releases
Catalyst Pharmaceuticals to Participate in the Bank of America CNS Therapeutics Virtual Conference
November 24, 2025
·
2 min read
Press Releases
Catalyst Pharmaceuticals to Participate in Jefferies Global Healthcare Conference
November 4, 2025
·
2 min read
Press Releases
Catalyst Pharmaceuticals to Participate in Citi’s 2025 Global Healthcare Conference
November 19, 2025
·
2 min read
Press Releases
Cellectis Announces 2026 Strategy and Catalysts
January 9, 2026
·
7 min read
Press Releases
Catalyst Pharmaceuticals Recognized Among BioSpace 2026 Best Places to Work
November 4, 2025
·
3 min read
Gene therapy
After Mortality-Marred Year, Sarepta Looks Ahead to Catalyst-Rich 2026
Jefferies analysts forecast a $1 billion market opportunity for each of Sarepta’s siRNA programs for facioscapulohumeral muscular dystrophy and myotonic dystrophy type 1.
January 13, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Worldwide Clinical Trials Enters Definitive Agreement to Acquire Catalyst Clinical Research
January 20, 2026
·
5 min read
1 of 74,151
Next
